By Alexander Bueso
Date: Monday 14 Sep 2020
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
No recent information was found.
| Currency | Euro | 
| Share Price | 280.29 | 
| Change Today | -4.72 | 
| % Change | -1.65 % | 
| 52 Week High | 330.00 | 
| 52 Week Low | 184.20 | 
| Volume | 5,281 | 
| Shares Issued | 8.35m | 
| Market Cap | 2,340.02m | 
| Beta | 0.61 | 
| Time | Volume / Share Price | 
| 11:30 | 5 @ 279.80 | 
| 11:30 | 26 @ 279.80 | 
| 11:25 | 2 @ 280.00 | 
| 11:25 | 1 @ 279.60 | 
| 11:24 | 1 @ 279.80 | 
You are here: research